Found "AI": 1,117 results
The Impact of Health Technology Assessment for the Support of Universal Health Coverage in Thailand
According to World Health Organization (WHO) health system framework an efficient health system results in equitable access to essential health technologies with assured quality, safety, efficacy, and cost-effectiveness. National policies, essential health technology list, and evidenced-based selection of health technologies using health technology
Online Trainings and Webinars
Given the impact of COVID-19, HITAP and partner organisation are committing to continue translating knowledge pieces and technical trainings collaboration in the virtual approach. Such virtual sessions refer to webinars engaged with guest lectureres in the fields, and modelling trainings by HITAP and partners. This initiative has been largely welco
The Physical Activity at Work (PAW): a cluster randomised trial of a multicomponent short-break intervention to reduce sitting time and increase physical activity among office workers in Thailand
Physical Activity at Work (PAW) program is a collaborative research between Health Intervention and Technology Assessment Program (HITAP), Department of Medical Services (DMS), Saw Swee Hock School of Public Health (SSHSPH) and Hitotsubashi University. As sedentary behaviours (SBs) are known to be associated with higher risks of all-cause mortality
HTA of COVID-19 vaccines in Thailand
To calibrate the Covid M SEIR model to Thailand and to build capacity to use the model to address policy questions in Thailand. This project will address COVID-19 vaccination policy questions, such as frequency and target population for booster doses, as well as development of web-based applications to communicate the results to policymakers and ot
Strengthen Capacity for Infectious Diseases Modelling in Thailand and Supporting the Use of Evidence to Respond to Pandemics Across the Asian Region and LMICs
Infectious disease modelling have played a defining role in managing the COVID-19 pandemic and their use is expected to rise owing to emerging disease outbreaks. Hence, countries have recognised the need to strengthen the capacity to use such models to prepare, manage, and exit outbreaks by answering difficult and dynamic policy questions. The
Development of reference case for economic evaluation on precision medicine for health insurance reimbursement in Thailand
The rapidly evolving healthcare landscape is being shaped by cutting-edge technologies such as big data analytics, digital advancements, and genomics, leading to the emergence of Precision Medicine (PM). National genomics programs worldwide are embracing PM\'s potential, signaling an imminent integration into healthcare systems. However, PM interve
Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients in the Thai healthcare system
The Thai healthcare system faces pressure to fund high-cost new branded pharmaceuticals. Paying more may encourage innovation with positive implications for future population health, but it also means less money is available to fund other healthcare with negative implications for current population health. Recent work in the UK estimated, for the f
Unlocking Networking, Initiatives, Training, and Expertise (UNITE) for Thailand Leadership in HTA
\"UNITE for Thailand\" is an initiative designed to cultivate the next generation of global health leaders, anchored by the Health Intervention and Technology Assessment Program (HITAP). The proposal acknowledges the critical role of effective leadership in addressing global health challenges and emphasizes the need for proactive support for early
Convergence of Digital Health Platforms and Health Information Systems (HIS) Implementation in Thailand (ConvergeDH) – Year 3
Digital health and Health Information Systems (HIS) are dramatically altering the landscape for health. Thailand achieved Universal Health Coverage (UHC) in 2002. However, the delivery of health services relies heavily on manpower without digitisation, and the COVID-19 pandemic has exposed the lack of adequate digital health platforms in the countr
Cost-Utility Analysis of Acetylcholinesterase inhibitors in the Treatment of Mild to Moderate Alzheimer’s disease (in Thai language)
The objective of this study is to estimate the cost-utility analysis of the cholinesterase inhibitors (i.e., donepezil, galantamine and rivastigmine) compared with no drug treatment in patients with mild to moderate alzheimer’s disease (AD) in Thailand based on the societal and governmental perspectives and to estimate the budget impact of the ch
10 / Page